JP2000517174A5 - - Google Patents

Download PDF

Info

Publication number
JP2000517174A5
JP2000517174A5 JP1998509953A JP50995398A JP2000517174A5 JP 2000517174 A5 JP2000517174 A5 JP 2000517174A5 JP 1998509953 A JP1998509953 A JP 1998509953A JP 50995398 A JP50995398 A JP 50995398A JP 2000517174 A5 JP2000517174 A5 JP 2000517174A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998509953A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000517174A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/014112 external-priority patent/WO1998006844A1/en
Publication of JP2000517174A publication Critical patent/JP2000517174A/ja
Publication of JP2000517174A5 publication Critical patent/JP2000517174A5/ja
Withdrawn legal-status Critical Current

Links

JP10509953A 1996-08-13 1997-08-13 ケラチノサイト増殖因子―2(kgf―2または線維芽細胞増殖因子―12、fgf―12) Withdrawn JP2000517174A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2385296P 1996-08-13 1996-08-13
US60/023,852 1996-08-13
US3904597P 1997-02-28 1997-02-28
US60/039,045 1997-02-28
PCT/US1997/014112 WO1998006844A1 (en) 1996-08-13 1997-08-13 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12)

Publications (2)

Publication Number Publication Date
JP2000517174A JP2000517174A (ja) 2000-12-26
JP2000517174A5 true JP2000517174A5 (enExample) 2005-04-07

Family

ID=26697695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10509953A Withdrawn JP2000517174A (ja) 1996-08-13 1997-08-13 ケラチノサイト増殖因子―2(kgf―2または線維芽細胞増殖因子―12、fgf―12)

Country Status (13)

Country Link
EP (1) EP0950100B1 (enExample)
JP (1) JP2000517174A (enExample)
KR (1) KR20000029986A (enExample)
CN (1) CN1234071A (enExample)
AT (1) ATE259420T1 (enExample)
AU (1) AU739773B2 (enExample)
CA (1) CA2263143A1 (enExample)
DE (1) DE69727589T2 (enExample)
DK (1) DK0950100T3 (enExample)
ES (1) ES2212121T3 (enExample)
NZ (1) NZ333725A (enExample)
PT (1) PT950100E (enExample)
WO (1) WO1998006844A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608182B1 (en) 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
US6734285B2 (en) 1994-03-08 2004-05-11 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 proteins and compositions
EP0751992B1 (en) 1994-03-08 2005-11-09 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US5932540A (en) 1994-03-08 1999-08-03 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7109308B1 (en) 1994-03-08 2006-09-19 Human Genome Sciences, Inc. Antibodies to human vascular endothelial growth factor 2
US7153827B1 (en) 1994-03-08 2006-12-26 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 and methods of use
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
US6040157A (en) 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US6077692A (en) * 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
AU775027C (en) * 1996-10-15 2005-12-08 Biovitrum Ab (Publ) Keratinocyte growth factor-2 products
EP1473366A1 (en) * 1996-10-15 2004-11-03 Amgen Inc. Keratinocyte growth factor-2 products
JP2001506975A (ja) * 1996-10-15 2001-05-29 アムジェン インコーポレイテッド ケラチノサイト増殖因子―2産物
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
CA2316015A1 (en) * 1997-12-22 1999-07-01 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
EP1054900A4 (en) * 1998-02-13 2004-12-22 Human Genome Sciences Inc THERAPEUTIC USE OF THE KERATINOCTENT GROWTH FACTOR-2
JP2002505873A (ja) * 1998-03-13 2002-02-26 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 血管内皮増殖因子2
US7223724B1 (en) 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
WO2000070046A2 (en) * 1999-05-14 2000-11-23 Curagen Corporation Secreted polypeptides and corresponding polynucleotides
AU5593200A (en) * 1999-06-02 2000-12-18 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
CN1211126C (zh) 2000-08-04 2005-07-20 人体基因组科学有限公司 血管内皮生长因子2
EP1357931A2 (en) * 2001-01-08 2003-11-05 Human Genome Sciences, Inc. Keratinocyte growth factor-2
DE60236646D1 (de) 2001-04-13 2010-07-22 Human Genome Sciences Inc Anti-VEGF-2 Antikörper
US7402312B2 (en) 2001-04-13 2008-07-22 Human Genome Sciences, Inc. Antibodies to vascular endothelial growth factor 2 (VEGF-2)
US8871709B2 (en) * 2003-02-05 2014-10-28 Queensland University of Technolgy Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
CN107041948A (zh) * 2009-01-21 2017-08-15 北京三有利科技发展有限公司 细胞生长因子治疗溃疡性疾病和肺纤维化疾病的应用
EP2393470B1 (en) * 2009-02-06 2017-04-05 The Regents of The University of California Calcium-binding agents induce hair growth and/or nail growth
CN102727890A (zh) * 2012-07-05 2012-10-17 吉林农业大学 抗重组人角质细胞生长因子-2抗体的应用
RU2016117275A (ru) 2013-11-01 2017-12-04 Сфериум Биомед С.Л. Тельца включения для трансдермальной доставки терапевтических и косметических средств
CN104474533A (zh) * 2014-11-24 2015-04-01 华南理工大学 一种可用于创面修复的复合微球的制备方法
CN104593320B (zh) * 2015-01-04 2017-05-17 许永安 一种汗腺分化诱导培养基及其应用
US9597274B2 (en) * 2015-06-17 2017-03-21 Avon Products, Inc. Peptides and their use in the treatment of skin
CN109402130A (zh) * 2018-11-23 2019-03-01 成都中医药大学附属医院 一种重组人角质细胞生长因子-1及其制备方法和用途
CN111588837B (zh) * 2020-05-14 2023-06-06 中南大学湘雅三医院 一种蛋白-纳米银复合物的制备方法及制备的复合物和用途
KR102440312B1 (ko) * 2020-08-28 2022-09-05 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도
CN112675294B (zh) * 2021-03-12 2021-05-14 诺赛联合(北京)生物医学科技有限公司 一种成纤维细胞的制备及在整形外科修复中的应用
WO2022204331A1 (en) * 2021-03-24 2022-09-29 Combangio, Inc. Compositions comprising branched kgf-2 derived peptides and methods for use in ocular treatment
EP4183796A1 (en) 2021-11-19 2023-05-24 Enantis s.r.o. Thermostable fgf10 polypeptide or fragment thereof use thereof
CN117736338A (zh) * 2023-12-08 2024-03-22 温州医科大学 一种角质细胞生长因子-透皮肽融合蛋白及其制备与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1323824A3 (en) * 1995-02-14 2004-01-21 Human Genome Sciences, Inc. Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions
JP2001506975A (ja) * 1996-10-15 2001-05-29 アムジェン インコーポレイテッド ケラチノサイト増殖因子―2産物

Similar Documents

Publication Publication Date Title
JP2000501771A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000516522A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000500874A5 (enExample)
JP2002514239A5 (enExample)
JP2000515272A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2001500092A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000517174A5 (enExample)
JP2000501876A5 (enExample)
JP2000509492A5 (enExample)
JP2000501229A5 (enExample)
JP2000500857A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)